Navigation Links
National Institute Of Health & Family Welfare To Commercialize Its Products

A Memorandum of Agreement was signed today between the National Institute of Health & Family Welfare (NIHFW) and National Research Development Corporation (NRDC) for transfer of technology developed by the NIHFW in the fields of Thermo Stable Elisa Kits and Laboratory Kits for Testing Sperm Functions. The up scaling of technologies developed by the Institute will be taken up by NRDC for commercialization. Prof. Deoki Nandan, Director, NIHFW and Mr. Somenath Ghosh, Chairman & Managing Director, NRDC signed the Memorandum of Agreement. This is the first time that the technology developed by NIHFW is being taken up for commercialization.

Thermo Stable Elisa Kits technology allows enzyme conjugate and antibody to retain their enzymatic and immunological activity respectively at 37oC for three months or more than two years at 2 to 8oC. The thermo stability technology for enzyme conjugate can have applicative value in those Elisa kits that are based on the use of enzyme horseradish peroxidase as label. The imported kits wherein horseradish peroxidase enzyme used are not thermo stable (can not with stand higher temperature of 37oC for more than twenty four hours). They require cold chain for their transport and storage. The new technologies are useful in production of Thermo-Stable Elisa Kits.

Three technological kits have been developed for testing Sperm functions. These will help to test many of the specialized functions of the sperms which otherwise are not routinely examined. It will strengthen the existing diagnostic tools in the male infertility diagnosis and management. It has the great potential to be routinely used in human sperm banks and can be extended in the same area for veterinary applications. At present no such laboratory kit for sperm function is available in the market. The kits do not require any imported material and have been developed indigenously.

In addition, the institute has also developed a vaginal co ntraceptives technology, which is water based, very much effective, less expansive and expected to provide wide acceptability.


'"/>




Related medicine news :

1. National Lung Study in the process
2. Indian Nationals with Foreign Medical Degrees can now practice in India
3. Hepatitis B Vaccine To Be Included In National Immunization Programme
4. UK Govt Says On Course For National Chlamydia Screening
5. Mexico and US border attain a new outlook due to BiNational Sustainability Laboratory
6. India extends National TB Control Program
7. President and Founder of National Obesity Forum Resigns
8. Hwang Woo Suk Suspended By Seoul National University
9. Indian National in Saudi Jail will be released soon
10. National Women and Girls HIV/AIDS Awareness Day
11. Calcutta National Medical College Strike Continues Unabated
Post Your Comments:
*Name:
*Comment:
*Email:


(Date:12/8/2016)... ... 08, 2016 , ... The Florida Hospital Tampa Wound Healing ... Society (UHMS), the leading authority in hyperbaric medicine. This accreditation identifies the Institute ... and facilities have earned this distinction. This is the second time the Florida ...
(Date:12/8/2016)... PLAINS, N.Y., and JENNERSVILLE, Pa. (PRWEB) , ... ... ... to announce that Penn Medicine Southern Chester County, a Property owned by an ... The $23 million, 72,000 square foot Penn Medicine Southern Chester County ambulatory care ...
(Date:12/8/2016)... ... December 08, 2016 , ... David J. Dykeman , ... firm Greenberg Traurig, LLP, will speak at DeviceTalks West, Dec. 12, 2016, at the ... series, and attorneys from the firm’s global Life Sciences & Medical Technology Group have ...
(Date:12/8/2016)... Somerset, N.J. (PRWEB) , ... December 08, 2016 ... ... advanced delivery technologies and development solutions for drugs, biologics and consumer health products, ... The PSCI was set up in 2006 as a non-profit organization to unite ...
(Date:12/8/2016)... ... December 08, 2016 , ... ... as possible. With this in mind, SIGVARIS has created a new line of ... during bed rest and provide the benefits of graduated compression when transitioning from ...
Breaking Medicine News(10 mins):
(Date:12/8/2016)...  Valeant Pharmaceuticals International, Inc. (NYSE: ... positive results from a Phase 3, multicenter double-blind, ... and efficacy of IDP-118 (halobetasol propionate and tazarotene) ... Within the Phase 3 study of ... IDP-118 showed statistical significance to vehicle with a ...
(Date:12/8/2016)... Information products and services provider Elsevier has launched ... largest abstract and citation database of peer-reviewed literature, providing the scholarly ... publishers. The new set of metrics will improve decisions on where ... a journal,s editorial strategy. ... , CiteScore metrics comprise a ...
(Date:12/8/2016)... 2016 Dignitana, a world leader in medical ... Technology, creator of the award-winning, patented Boa® system, to ... the DigniCap® scalp cooling system. DigniCap® was cleared by ... and is the first medical scalp cooling device to ... system features a patented tight-fitting silicone cooling cap that ...
Breaking Medicine Technology: